Analyst Ratings for Valeant Pharmaceuticals International Inc. (VRX)

Updated: 2017-07-26

An average rating of Hold has been given to Valeant Pharmaceuticals International Inc. (NYSE:VRX) by analysts covering the stock. A consensus rating of Hold was previously issued for VRX last month.

A buy rating was issued by 3 analysts, 1 gave an overweight rating, 13 gave a hold rating, 1 gave an underweight rating, and 4 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 1. During this time, the number of analysts bearish on the stock has increased by 0.

Many analysts weighed in on price targets for VRX. The highest price target was 35, implying potential capital gains of 95.26 percent. The most pessimistic price target was 8, which equates to a potential downside of -55.37 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0.53 percent. The average change in earnings estimates over the last 90 days is 0.54 percent. Over the past 30 days, FY earnings estimates have also changed downwards by -0.27 percent. If we look at the last 90 days instead, we find a net average change of -6.2 percent in FY estimates.

People are often interested in whether analysts were united in the direction of their revisions. 2 analysts have revised their quarterly estimates upwards in the past 30 days, while 0 analysts made negative revisions. Over the same time period, 2 analysts revised their FY earnings estimates upwards, while 2 analysts decreased their estimates.

VRX has a 52-week high of 32.75 and a 52-week low of 8.31. Currently the stock is 115.7 percent higher than its low, and 45.27 percent lower than its 52-week high. VRX has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The VRX value stock report compares VRX to some of its peers using value stock charts. The stock has a market capitalization of $7.72 billion. VRX's next earnings release will be on 0000-00-00, which is days away.